Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015 Provides Second Quarter and Year End Dividend Guidance for Full Year of the Fiscal Year Ending March 31, 2016; Provides Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2016
July 23, 2015
Share
Ekien Chemical Co., Ltd. announced consolidated earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales of JPY 7,831 million compared with JPY 7,665 million for the same period in the last year. Operating income was JPY 864 million compared with JPY 773 million for the same period in the last year. Ordinary income was JPY 883 million compared with JPY 814 million for the same period in the last year. Net income attributable to shareholders of the parent company was JPY 617 million compared with JPY 565 million for the same period in the last year. Diluted net income per share was JPY 33.46 compared with JPY 30.67 for the same period in the last year.
For the second quarter, the company expects dividend of JPY 20.00 per share compared with JPY 17.00 per share for the same period in the last year.
The company expects year end dividend of JPY 20.00 per share compared with JPY 187.00 per share for the same period in the last year.
The company provided earnings guidance for the first half and full year for fiscal year ending March 2016. For the first half, the company expects net sales of JPY 16,830 million, operating income of JPY 1,920 million, ordinary income of JPY 1,940 million, net income attributable to shareholders of the parent company of JPY 1,350 million and net income per share of JPY 73.79.
For the year ending March 31, 2016, the company expects net sales of JPY 32,820 million, operating income of JPY 3,330 million, ordinary income of JPY 3,350 million, net income attributable to shareholders of the parent company of JPY 2,180 million and net income per share of JPY 119.15.
EIKEN CHEMICAL CO., LTD. is a Japan-based company principally engaged in the manufacture and sale of test drugs. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015 Provides Second Quarter and Year End Dividend Guidance for Full Year of the Fiscal Year Ending March 31, 2016; Provides Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2016